Poly Medicure (NSE:POLYMED) Debt-to-Equity : 0.12 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Poly Medicure Debt-to-Equity?

Poly Medicure's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹1,710 Mil. Poly Medicure's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹32 Mil. Poly Medicure's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹14,701 Mil. Poly Medicure's debt to equity for the quarter that ended in Mar. 2024 was 0.12.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Poly Medicure's Debt-to-Equity or its related term are showing as below:

NSE:POLYMED' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.12 Med: 0.33 Max: 0.48
Current: 0.12

During the past 13 years, the highest Debt-to-Equity Ratio of Poly Medicure was 0.48. The lowest was 0.12. And the median was 0.33.

NSE:POLYMED's Debt-to-Equity is ranked better than
65.38% of 699 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs NSE:POLYMED: 0.12

Poly Medicure Debt-to-Equity Historical Data

The historical data trend for Poly Medicure's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poly Medicure Debt-to-Equity Chart

Poly Medicure Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

0.48

0.14

0.12

Poly Medicure Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.12	N/A	0.10	N/A	0.12

Competitive Comparison of Poly Medicure's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Poly Medicure's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poly Medicure's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Poly Medicure's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Poly Medicure's Debt-to-Equity falls into.

Poly Medicure Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Poly Medicure's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1709.772	+	31.751)	/	14700.535
	=	0.12

Poly Medicure's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1709.772	+	31.751)	/	14700.535
	=	0.12

Poly Medicure (NSE:POLYMED) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Poly Medicure Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Poly Medicure's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Poly Medicure (NSE:POLYMED) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Poly Medicure Ltd (NSE:POLYMED) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

531768:India

Address

Okhla Industrial Estate, 232-B, 3rd Floor, Phase III, New Delhi, IND, 110020

Website

https://www.polymedicure.com

Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.

Poly Medicure (NSE:POLYMED) Headlines

No Headlines